// COMPANY
SPR Therapeutics
SECTOR HEALTHTECHMENTIONS 9LAST SEEN AUGUST 2, 2026
// OVERVIEW
Cleveland-based provider of peripheral nerve stimulation therapies for chronic pain management; raised ~$172M from VCs before $650M acquisition by Medtronic.
Discussed in
// RECENT MENTIONS
// SIGNALS
9 SIGNALS
01
funding·Data Driven VC·AUGUST 2, 2026
“Senior Scientist at Stoke Therapeutics ($293M raised, RNA-targeted therapeutics).”
Source→02
funding·Axios Pro Rata·JULY 27, 2026
“Scribe Therapeutics, Molecular engineering / CRISPR startup, Successful IPO, priced at high end, closed 44% above IPO price. 'raised $129m in its IPO... closed Friday trading at $21.65'”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.